This retrospective study investigates the clinical diagnostic workflow and therapeutic efficacy of different treatment strategies for elderly patients with cardiovascular heart failure. We enrolled 120 inpatients aged 65 or older treated between January 2022 and December 2024. A multimodal diagnostic approach—comprising electrocardiography, echocardiography, BNP/NT-proBNP measurement, and right-heart catheterization—was compared in terms of diagnostic accuracy and early disease staging. Therapeutically, patients were stratified by disease severity and received diuretics, ACE inhibitors or ARBs, beta-blockers, and mineralocorticoid receptor antagonists; a subset of severe cases also underwent cardiac resynchronization therapy (CRT) or implantable cardioverter-defibrillator (ICD) placement. We evaluated short-term (3-month) and mid- to long-term (12-month) outcomes by monitoring left ventricular ejection fraction (LVEF), six-minute walk distance (6MWD), rehospitalization rate, and one-year overall survival. The multimodal diagnostic strategy significantly improved early detection rates, while the combined treatment regimen notably enhanced LVEF and reduced the risk of rehospitalization. CRT/ICD support conferred additional prognostic benefits in the most severe subgroup. Our findings suggest that individualized diagnostic and therapeutic pathways can optimize clinical outcomes and resource utilization in elderly heart failure patients, providing an evidence base for standardized care protocols.

Zhu Hezhong. Clinical Diagnosis and Treatment Outcome Analysis of Cardiovascular Heart Failure in the Elderly. Academic Journal of Medicine & Health Sciences (2025), Vol. 6, Issue 5: 13-19. https://doi.org/10.25236/AJMHS.2025.060503.

[1] Tersalvi, Gregorio, et al. "Acute heart failure in elderly patients: a review of invasive and non-invasive management." Journal of geriatric cardiology: JGC 18.7 (2021): 560.

[2] Fuentes-Abolafio, Iván José, et al. "Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis." BMC cardiovascular disorders 20 (2020): 1-23.

[3] Sato, Masayuki, et al. "Clinical characteristics and prognostic factors in elderly patients with chronic heart failure-A report from the CHART-2 study." IJC Heart & Vasculature 27 (2020): 100497.

[4] Castiglione, Vincenzo, et al. "Biomarkers for the diagnosis and management of heart failure." Heart failure reviews (2022): 1-19.

[5] Kitzman, Dalane W., et al. "Physical rehabilitation for older patients hospitalized for heart failure." New England Journal of Medicine 385.3 (2021): 203-216.

[6] Takashio, Seiji, et al. "Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy." ESC Heart Failure 10.4 (2023): 2319-2329.

[7] Upadhya, Bharathi, and Dalane W. Kitzman. "Heart failure with preserved ejection fraction: new approaches to diagnosis and management." Clinical cardiology 43.2 (2020): 145-155.

[8] Assefa, Erkihun, et al. "Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study." BMC Cardiovascular Disorders 23.1 (2023): 26.

[9] Sciacqua, Angela, et al. "Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond." Heart failure reviews (2021): 1-15.

[10] Park, Jin Joo. "Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes." Diabetes & metabolism journal 45.2 (2021): 146-157.